doi: 10.3389/fphys.2020.00973 Received 09 June 2020 Accepted 16 July 2020 Published 23 September 2020 Volume 11 - 2020 Edited by Richard Albert Hawkins, Chicago Medical School, United States Reviewed by Kosman Daniel, University at Buffalo, United States
These findings preview potential outcomes from a pending human clinical study, offering formulators early insights into long-term supplementation patterns
1) Personalize your doseand your taper Reach and hold an effective dose: meaningful appetite suppression often happens only after full titration
That focus is especially important for people using GLP-1 medications
No bloating, no weird side effects
Jones MT, Mahler H christian, Yadav S, et al